O'Donnell M E
Department of Human Physiology, School of Medicine, University of California, Davis 95616.
J Biol Chem. 1991 Jun 25;266(18):11559-66.
Previous studies have shown that vascular endothelial cells exhibit a highly active Na-K-Cl cotransport system that is regulated by a variety of vasoactive hormones and neurotransmitters, suggesting that the cotransporter may play an important role in endothelial cell function. In this study, the regulation of endothelial cell Na-K-Cl cotransport was further investigated by probing the stimulus-transfer pathway by which vasoactive agents stimulate the cotransporter. Specifically, three peptides previously shown to stimulate cotransport activity (angiotensin II, vasopressin, and bradykinin) were evaluated. Na-K-Cl cotransport was assessed in cultured bovine aortic endothelial cells as bumetanide-sensitive K+ influx. Stimulation of Na-K-Cl cotransport by angiotensin II, vasopressin, or bradykinin was found to be reduced either by removal of extracellular Ca2+ or by treatment of the cells with 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate or 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid. In addition, the calmodulin antagonist W-7 was found to prevent stimulation of endothelial cell Na-K-Cl cotransport by the three peptides. These findings suggest that regulation of endothelial cell cotransport by these vasoactive peptides may be both Ca(2+)- and calmodulin-dependent. Angiotensin II, vasopressin, and bradykinin were also found to elevate phosphatidylinositol hydrolysis in the cultured endothelial cells. Thus, the possibility that regulation of endothelial Na-K-Cl cotransport by these vasoactive peptides also involves diacylglycerol activation of protein kinase C was investigated. A 10-min exposure of the endothelial cells to low doses of phorbol 12-myristate 13-acetate was found to reduce Na-K-Cl cotransport whether in the presence or absence of angiotensin II, vasopressin, or bradykinin. However, down-regulation of protein kinase C by a 40-h exposure to higher doses of the phorbol ester was found to elevate Na-K-Cl cotransport activity under both control and agonist-stimulated conditions, indicating that activation of protein kinase C results in inhibition of endothelial cell Na-K-Cl cotransport. Thus, protein kinase C activation may serve as negative feedback in the stimulus-transfer pathway by which these agonists regulate endothelial cell Na-K-Cl cotransport.
先前的研究表明,血管内皮细胞呈现出一种高度活跃的钠 - 钾 - 氯协同转运系统,该系统受多种血管活性激素和神经递质的调节,这表明该协同转运体可能在内皮细胞功能中发挥重要作用。在本研究中,通过探究血管活性物质刺激该协同转运体的刺激传递途径,进一步研究了内皮细胞钠 - 钾 - 氯协同转运的调节机制。具体而言,评估了先前已证明能刺激协同转运活性的三种肽(血管紧张素 II、血管加压素和缓激肽)。在培养的牛主动脉内皮细胞中,将钠 - 钾 - 氯协同转运评估为布美他尼敏感的钾离子内流。发现去除细胞外钙离子或用 8 -(N,N - 二乙氨基)辛基 - 3,4,5 - 三甲氧基苯甲酸酯或 1,2 - 双(邻氨基苯氧基)乙烷 - N,N,N',N' - 四乙酸处理细胞后,血管紧张素 II、血管加压素或缓激肽对钠 - 钾 - 氯协同转运的刺激作用减弱。此外,发现钙调蛋白拮抗剂 W - 7 可阻止这三种肽对内皮细胞钠 - 钾 - 氯协同转运的刺激。这些发现表明,这些血管活性肽对内皮细胞协同转运的调节可能依赖于钙离子和钙调蛋白。还发现血管紧张素 II、血管加压素和缓激肽可提高培养的内皮细胞中磷脂酰肌醇的水解。因此,研究了这些血管活性肽对内皮细胞钠 - 钾 - 氯协同转运的调节是否也涉及二酰基甘油对蛋白激酶 C 的激活。发现内皮细胞暴露于低剂量佛波醇 12 - 肉豆蔻酸酯 13 - 乙酸酯 10 分钟后,无论是否存在血管紧张素 II、血管加压素或缓激肽,钠 - 钾 - 氯协同转运都会降低。然而,发现内皮细胞在较高剂量佛波醇酯中暴露 40 小时导致蛋白激酶 C 下调后,在对照和激动剂刺激条件下钠 - 钾 - 氯协同转运活性均升高,这表明蛋白激酶 C 的激活会导致内皮细胞钠 - 钾 - 氯协同转运受到抑制。因此,蛋白激酶 C 的激活可能在这些激动剂调节内皮细胞钠 - 钾 - 氯协同转运的刺激传递途径中起到负反馈作用。